H5N1 viruses and vaccines.
Subbarao
Kanta
K
Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland, United States of America. ksubbarao@niaid.nih.gov
Luke
Catherine
C
D000818:Animals; D002986:Clinical Trials as Topic; D004196:Disease Outbreaks / Q000517:prevention & control; D015195:Drug Design; D005289:Ferrets; D006801:Humans; D053124:Influenza A Virus, H5N1 Subtype / Q000276:immunology / Q000472:pathogenicity*; D007252:Influenza Vaccines / Q000276:immunology / Q000627:therapeutic use*; D007251:Influenza, Human / Q000276:immunology / Q000517:prevention & control*; D051379:Mice; D016865:Reassortant Viruses / Q000302:isolation & purification / Q000472:pathogenicity; D014611:Vaccination
D007252:Influenza Vaccines